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ABSTRACT 
The aim of the study is protective effect of compound Eclipta alba and Ocimum sanctum on Parkinsonism induced mice by 
haloperidol injection. Parkinsonism is neurodegenerative disease due to the deficiency of dopamine in brain. The pathological 
hallmark of Parkinson’s disease in the cell loss within substantia nigra pars compacta (SNpc) region and the disease is charactrised 
by bradykinesia, rigidity, postural instability, orofacial dyskinesia, muscular stiffness and tremor1. Mice were injected 1mg/kg 
haloperidol and then treated with test and standard substance for 15 days. The impairment in catatonia in mice were tested using 
catatonic activity. Biochemical analysis of brain homogenate was performed so ass to assess brain Thiobarbituric acid reactive 
substance (TBARS) level and reduced glutathione (GSH) and TNF-α level were measured to assess total oxidative stress. EA 
300mg/kg and OS 400mg/kg show slightly change in catatonic activity in mice while EA 600mg/kg and 800mg/kg significantly 
change in catatonic activity. Furthermore, Eclipta alba and Ocimum sanctum prevent the haloperidol induced changes in the level of 
brain TBARS, GSH and TNF-α. From the results we conclude that Eclipta alba and Ocimum sanctum has protective action against 
impairment in catatonic activity and pathological damage due to oxidative stress induced by intraperitoneally injection of haloperidol 
in mice.        
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INTRODUCTION 
Neurodegenerative diseases were believed to be 
incurable and debilitating conditions, which primarily 
affected the neurons in the human brain resulting in the 
loss of nerve structure and function and ultimately 
leading to the death of nerve cells. The major 
characteristic features of neurodegenerative diseases 
include ataxias (impairment in movement) and dementia 
(decline in memory).The three main types of 
neurodegenerative diseases that affect the life quality 
and life span of the elderly include Alzheimer’s disease 
(AD), Parkinson’s disease (PD), and Huntington’s 
disease (HD)
2
. Haloperidol (HP) belongs to the group of 
typical incisive antipsychotics. It is highly potent drug 
used particularly in the management of acute states, 
such as psychosis, manic phases, hyperactivity, 
aggressiveness, and acute delirium; in some cases, it is 
administered on a long-term basis
3
. Reactive oxygen 
species (ROS) are chemically reactive molecules 
containing oxygen and are produced in all aerobic cells. 
Oxidative stress occurs when the generation of ROS in a 
system exceeds that system’s ability to neutralize and to 
eliminate them. All organisms have developed adaptive 
responses to oxidative stress that involve defensive 
enzyme and molecular chaperones—the expression of 
both being orchestrated by stress-responsive 
transcription factors—as well as antioxidant molecules4.  
 Antioxidants mainly act by:  
1. Inhibiting the NADPH oxidase and reduce NADPH 
oxidase-mediated generation of reactive oxygen species.  
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2. Balance NO production from different NO synthase 
isoforms.  
3. Reducing neuroiniflammation via attenuation of the 
release of cytokines and down regulation of the pro-
inflammatory transcription factors.  
4. Modulating signaling pathways such as mitogen-
activated protein kinase cascade and cAMP response 
element binding protein are responsible for the 
neuroprotective actions of different natural 
polyphenols
5
.  
MATERIALS AND METHODS 
Swiss albino mice of either sex weighing 25±2g were 
employed in present study. The animals were housed in 
the departmental animal house and were exposed to 
12hr light and dark cycle. The animals were 
acclimatized to the laboratory conditions before 
experiments. The experimental protocol was duly 
approved by the institutional animal ethical committee. 
Preparation of Aqueous extract of E. alba  
The entire, dried plant was then coarsely powdered and 
the purity and quality of the crude drug was established 
as per the procedures laid down in Indian 
Pharmacopoeia 1996. The powdered plant material was 
then subjected to extraction with water by decoction for 
18 h in Soxhlet’s extractor, to obtain the aqueous 
extracts. The yield of aqueous extract (Aq. Ext.) was 
found to be 31.44% (w/w). Preliminary phytochemical 
investigations conducted as per the procedures described 
by Kokate (1994) and Trease and Evans (1997) of the 
extracts revealed the presence of saponins, tannins, 
carbohydrates and phenolic compounds
6
. 
Preparation of alcoholic extract of Ocimum 
sanctum 
The leaves of OS were collected, authenticated, air dried 
and powdered. The extract was prepared from this 
powder (1 kg) by percolation with 70% ethyl alcohol at 
room temperature and was then concentrated under 
reduced pressure (below a temperature of 50 ◦C). It was 
finally vacuum dried in a lyophliser (Herysun 
Instruments Co.). The yield of the extract was 1 g/100 g 
powder. This extract was dissolved in Tween 80 for 
administration in animals
7
. 
Administration of extraxt of E. alba and 
Ocimum Sanctum 
The test substances were administered to animals by 
oral gavage as a single dose using oral gavaging tube. 
The dosage volume administered to individual mice was 
adjusted according to its body weight recorded on the 
day of dosing. The animals were administered with 
300mg/kg body weight
8
.  
Drug and Chemical 
Bromocriptine (Proctinal®, 2.5mg/Tablet, Glaxo 
Smithkline Pharmaceuticals Ltd, Mumbai, India) 
suspended in tween 80, were given orally and used as 
reference standard drugs in this study. Haloperidol 
(Serenace®, 5mg/ml, RPG Life Sciences Ltd, Mumbai, 
India). 
Brain Tissue Sampling and Preparation  
After completion of behaviour tests, the animals were 
kept fasting for 12 hours. Blood samples were collected 
using the orbital sinus technique of Sandford18. The 
mice were killed by decapitation and the whole brain of 
each animal was rapidly dissected, thoroughly washed 
with isotonic saline, dried and then weighed. The brain 
was homogenized with ice-cold 0.1M phosphate buffer 
(pH 7.4, 10% (w/v). The homogenate was centrifuged at 
3000 rpm for 10 min at 4ºC. The supernatant (10%) was 
separated for biochemical analysis. 
Methodology for catatonic mice 
Various stages of catatonia were induced in mice with 
haloperidol
9,10
. The standard and test substance were 
administered 30min prior to haloperidol injection and 
scoring was made at 15, 30, 45, 60 and 90 after the 
injection. The development and severity of the four 
stages of induced catatonia were observed and score as 
follow:  
Stage I: Rat moves normally when placed on the table, 
score=0.  
Stage II: Rat moves only when touched or pushed, 
score=0.5.  
Stage III: Rat placed on the table with front paws set 
alternatively on 3cm high block fails to correct the 
posture in 10 sec, score=0.5 for each paw with a total of 
1 for this stage.  
Stage IV: Rat fails to remove when the front paws are 
placed alternatively on 9cm block, score= 1 for each 
paw a total score of 2 for this stage.  
Thus, for a single mouse, the maximum possible score 
would be 3.5 revealing total catatonia and less score 
would mean an apparently lesser degree of catatonia. 
The day after completion of catatonic response mice 
were sacrificed and biochemical parameters were 
estimated like Brain Dopamine, Brain Thiobarbituric 
acid reactive substance (TBARs), Brain reduced 
Glutathione (GSH), Locomotor activity, alteration in 
these parameter shows the activity of the test and 
standard drugs. 
Experimental Design 
Group I (Catatonia control): Catatonia control group 
were treated with 1mg/kg Haloperidol intraperitoneally. 
Group II (Standard-1 treated group): Standard 1 
group were infected with 1mg/kg Haloperidol to induce 
catatonia in mice and treated with Bromocriptine 
30mg/kg/day and code as SD-I 
Group III (Test dose-1 treated group): Test-1 group 
were infected with 1mg/kg Haloperidol to induce 
catatonia in mice and treated with extract of E. alba 
300mg/kg/day and code as test-1 
Group IV (Test dose-2 treated group): Test-2 group 
were infected with 1mg/kg Haloperidol to induce 
catatonia in mice and treated with extract of E. alba 
600mg/kg/day and code as test-2 
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Group V (Test dose-3 treated group): Test-3 group 
were infected with 1mg/kg Haloperidol to induce 
catatonia in mice and treated with extract of OS 
400mg/kg/day and code as test-3 
Group VI (Test dose-4 treated group): Test-4 group 
were infected with 1mg/kg Haloperidol to induce 
catatonia in mice and treated with extract of OS 
800mg/kg/day and code as test-4 
RESULTS 
Effect on Catatonic behavioral 
It was observed that haloperidol 1mg/kg administered 
i.p alone treated group, significantly increased the 
catalepsy 15
th
 day as compared to vehicle treated group. 
In Bromocriptine treated group significantly decrease in 
catalepsy score (p<0.001) was seen 15
th
 day, as 
compared to haloperidol treated group. EA 300mg/kg 
and OS 400mg/kg 30 min. pretreated groups did cause 
slightly change in catalepsy score on 15
th
 day. When 
compared with standard treated group. But on 15
th
 day, 
whereas EA 600mg/kg and OS 800mg/kg 30 min. 
pretreated treated group was marked decrease in 
catalepsy score (p<0.001) when compared with standard 
treated group in dose dependent manner. 
 
 
Figure 1: Effect on Catatonic behavioral 
 
Effect on Brain TBARS Activity 
Haloperidol treated group significantly increase the 
TBARS activity on 15
th
 day as compare to normal group 
and reflecting enhanced oxidative stress. Treatment with 
EA 300mg/kg and OS 400mg/kg per se group had 
slightly decreased in TBARS activity as compare to 
catatonic control group. But when it was compared with 
standard groups their results are slightly increase, 
whereas EA 600mg/kg and OS 800mg/kg treated group 
significantly abolished the haloperidol induced rise in 
brain oxidative stress level in dose dependent manner. 
 
 
Figure 2: Effect on Brain TBARS Activity 
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Effect on Brain GSH Activity 
Haloperidol treated group significantly reduce the 
glutathione activity on 15
th
 day as compare to normal 
group and reflecting enhanced oxidative stress. 
Treatment with EA 300mg/kg and OS 400mg/kg per se 
group had slightly increased in glutathione activity as 
compare to catatonic control group. But when it was 
compared with standard groups their results are slightly 
decrease in activity, Whereas EA 600mg/kg and OS 
800mg/kg treated group significantly abolished the 
haloperidol induced rise in brain oxidative stress level 
and significantly increase the level of glutathione in dose 
dependent manner. 
 
 
Figure 3: Effect on Brain GSH Activity 
 
Effect on Brain TNF-α Activity 
Haloperidol treated group significantly increase in TNF- 
α activity on 15th day as compare to normal group and 
reflecting enhanced oxidative stress. Treatment with EA 
300mg/kg and OS 400mg/kg per se group had slightly 
decreased in TNF- α activity as compare to catatonic 
control group. But when it was compared with standard 
groups their results are significantly higher in TNF- α 
activity, Whereas EA 600mg/kg and OS 800mg/kg 
treated group significantly abolished the haloperidol 
induced rise in brain oxidative stress level and 
significantly decrease the level of TNF- α in dose 
dependent manner. 
 
 
Figure 4: Effect on Brain TNF-α Activity 
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DISCUSSION 
In our study, mice were selected to induce catalepsy 
with haloperidol due to blockage of striatal D2 
receptor
12
. 
Haloperidol remains effective in inducing catalepsy and 
striatal Fos/Jun expression in the D1 mutants, and these 
behavioral and neural effects can be blocked by D2 
dopamine receptor agonists
13
. Catalepsy occurs when 
more than 80% of D2 receptors are occupied by the 
drug
14
. Catalepsy is also driven by the excitatory 
adenosine and glutamatergic inputs acting on adenosine 
A2A and N-methyl-D-aspartate (NMDA) receptors in 
the striatum. This is because NMDA receptor 
antagonists
15
. The previous data shows that Maximum 
cataleptic store is observed after 60 and 90 min of 
administration. The free radical’s production can be 
inactivated by free radical scavenging system. In PD, 
substantia nigra is conductive to the formation of 
cytotoxic free radicals. These free radicals cause lipid 
peroxidation and cell death, which shows that it leads to 
a severe oxidative state in SN. Increased oxidative stress 
leads to over consumption of SOD, GPX and show 
movement disorders
16
. so in the present study it is 
necessary to assess the cataleptic score. In our study 
cataleptic score was increase with intraperitoneally 
injection of haloperidol for 15 days and test and 
standard drugs was given 30 min prior to the haloperidol 
injection. From the results test drugs shows that 
cataleptic score was decrease or come close to standard 
drug. 
Several studies show that depletion of the antioxidant 
peptide glutathione (GSH) in PD cells, which may be 
caused by a decrease in its synthesis and recycling
17
. 
The hallmark of idiopathic Parkinson's disease (PD) is 
loss of dopaminergic neurons in the substantia nigra 
pars compacta (SNpc), leading to the major clinical and 
pharmacological abnormalities that characterize the 
disease. The most robust and significant alteration in the 
antioxidant defense is a decrease in GSH concentration. 
Initially, a complete absence of GSH in the presence of 
high GSSG concentrations was reported. However, in 
the brain most of the GSH is localized in glia. The levels 
of glutathione transferase, a protective enzyme against 
aldehydes and especially HNE were decreased in the 
brain and ventricular CSF of autopsied AD and normal 
control subjects
18
. In our study GSH activity is decrease 
by haloperidol in different groups due to oxidative stress 
or generation of free radicals. From the results GSH 
activity in test drugs show same or come close to 
standard drug i.e standard 1 in dose dependent manner. 
Haloperidol (HP) is converted to potentially toxic 
(HHP+) metabolites which may play a role in the 
extrapyrimidal side effects which are observed in the 
patients who are treated with haloperidol. Another 
possible mechanism could be the effect of neuroleptics 
on the mitochondrial respiration. The metabolites of 
haloperidol inhibit complex-I of the electron transport 
chain. The capability of the anti-psychotic drugs to 
clinically induce the extra-pyramidal syndrome seems to 
correlate well with their inhibitory effect on the 
complex- I inhibition. Whatever could have been be the 
mechanism of the unbalanced production of the reactive 
oxygen species (ROS) and the oxidative stress by 
haloperidol
19
. Increased TBARS activity has been 
shown to be an important marker for in vivo lipid 
peroxidation in the learning and memory deficient 
mouse brains. In addition, it has been reported that 
haloperidol significantly increases TBARS activity in 
the hippocampus and frontal cortex
11, 20
. From the 
results we know that standard-1 decrease the TBARS 
level in brain, but test substance reduces the level of 
TBARS in dose dependent manner. 
On treating with haloperidol resulted in significantly 
increases in the level of TNF-α in the cortex and 
striatum region of the mice brain. Many cellular studies 
indicated that haloperidol has been associated with an 
increased expression of inflammatory markers such as 
TNF-α and NF-kB against oxidative damage induced by 
haloperidol that may lead to neurotoxicity
21
.However, 
with chronic haloperidol, there is a downregulation of 
phospho-Thr34-DARPP-32 because of an increase in 
TNFα signaling. In the CNS, the effects of TNFα are 
complex, with evidence for both injury-promoting and 
neuroprotective effects. Moreover, TNFα levels are 
elevated in patients and animal model of movement 
disorder, such as HD, PD, and other basal ganglia 
disorders, such as OCD, schizophrenia, and addiction. 
Overall, our data establish that TNFα is a key element in 
maintaining the normal function of this circuit and that 
the robustness of striatal compensatory systems may set 
the symptom susceptibility in these maladies
22
. When 
measured in whole brain, levels of TNF-α were 
decreased but when studied in selective striatal regions 
as in our study, levels were significantly increased
23
. So, 
it is necessary to find TNF-α activity in present study. In 
our study haloperidol injection 1mg/kg decrease in 
TNF-α after 30min. of test-(1,2,3,4) and standard-1. 
From the results test drugs show increase or come close 
to standard-1 in dose dependent manner 
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